Table 1:
Subject demographics and information of the clinical and experimental strategies.
| Age (years) |
Etiology | Years with CI |
Clinical strategy | Experimental strategies | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strategy | Main ELs used |
Pulse phase duration (μs) |
Pulse rate (pps) |
SRT (dB) |
Main ELs used |
Pulse phase duration (μs) |
Pulse rate (pps) |
σ used |
||||
| S1 | 65 | Unknown | 6 | HiRes120-S | 1-14 | 18 | 3712 | 8.8 | 2-13 | 140 | 297 | 0.75 |
| S2 | 25 | Genetic | 2 | HiRes120-S | 1-16 | 26 | 2560 | 4.0 | 2-14 | 140 | 275 | 0.625 |
| S3 | 86 | Sudden HL | 6 | HiRes120-P | 1-16 | 18 | 3712 | 11.0 | 2-15 | 140 | 255 | 0.625 |
| S4 | 68 | Hereditary | 9 | HiRes-P | 1-16 | 25 | 2486 | 16.0 | 2-15 | 140 | 255 | 0.75 |
| S5 | 55 | Unknown | 8 | HiRes120-P | 1-15 | 20 | 3228 | 10.2 | 2-13 | 140 | 297 | 0.625 |
| S6 | 56 | Unknown | 8 | HiRes120-S | 1-16 | 49 | 1350 | 10.0 | 2-15 | 140 | 255 | 0.625 |
| S7 | 67 | Unknown | 3 | HiRes120-P | 1-13 | 18 | 3712 | 17.0 | 2-13 | 140 | 297 | 0.75 |
| S8 | 61 | AN Loss | 13 | HiRes120-S | 1-16 | 24 | 2750 | 12.7 | 2-15 | 140 | 255 | 0.75 |
| S9 | 66 | Osteoporosis | 5 | HiRes-S | 1-16 | 33 | 2007 | 15.9 | 2-15 | 140 | 255 | 0.75 |
| S10 | 73 | Unknown | 10 | HiRes-S | 1-14 | 18 | 3712 | 11.0 | 2-13 | 140 | 297 | 0.625 |
CI, cochlear implant; EL, electrode; pps, pulses per second; SRT, speech reception threshold; S, sequential stimulation; P, paired stimulation; HL, hearing loss; AN, auditory nerve.